3-Year Follow-up Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

Authors :: Sattva S. Neelapu
Julio C. Chavez
Alison R. Sehgal
Narendranath Epperla
Matthew L. Ulrickson
Emmanuel Bachy
Pashna N. Munshi
Carla Casulo
David G. Maloney
Sven de Vos
Ran Reshef
Lori A. Leslie
Olalekan O. Oluwole
Ibrahim Yakoub-Agha
Rashmi Khanal
Joseph Rosenblatt
Jiali Yan
Qinghua Song
Weixin Peng
Christine Lui
Jacob Wulf
Rhine R. Shen
Soumya Poddar
Harry Miao
Sara Beygi
Caron A. Jacobson
Source :: Transplantation and Cellular Therapy. 29:S374
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Subjects :: Transplantation
Molecular Medicine
Immunology and Allergy
Cell Biology
Hematology

Tools